12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the performance of 12 health care stocks during Friday's after-market session. Notable gainers include Kineta (KA), iSpecimen (ISPC), ENDRA Life Sciences (NDRA), Brainstorm Cell (BCLI), Bullfrog AI Holdings (BFRG), and Can Fite Biofarma (CANF). On the losing side, Nexalin Technology (NXL), Scinai Immunotherapeutics (SCNI), Ontrak (OTRK), AN2 Therapeutics (ANTX), CERo Therapeutics Holdings (CERO), and Renovaro (RENB) saw declines.
June 14, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Brainstorm Cell (BCLI) shares rose by 9.08% to $0.51, with a market value of $35.9 million.
The increase in share price suggests positive developments or investor sentiment towards the company.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
Bullfrog AI Holdings (BFRG) stock increased by 7.53% to $2.71, with a market cap of $21.2 million.
The stock's rise indicates positive market sentiment or news related to the company.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
Can Fite Biofarma (CANF) stock increased by 7.46% to $3.6, with a market cap of $17.9 million.
The stock's increase suggests positive developments or investor sentiment towards the company.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
iSpecimen (ISPC) stock rose by 13.99% to $0.57, with a market value of $5.6 million.
The notable price increase suggests positive sentiment or developments for the company.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Kineta (KA) shares surged by 28.5% to $0.67, with a market cap of $8.1 million.
The significant price increase indicates strong investor interest or positive news related to the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
ENDRA Life Sciences (NDRA) shares increased by 11.0% to $0.12, with a market value of $1.9 million.
The price increase indicates a positive market reaction, possibly due to favorable news or investor sentiment.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
AN2 Therapeutics (ANTX) stock declined by 7.38% to $2.01, with a market cap of $59.9 million.
The stock's decline suggests negative developments or investor sentiment towards the company.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
CERo Therapeutics Holdings (CERO) shares decreased by 6.03% to $0.36, with a market cap of $5.3 million.
The decrease in share price indicates negative market reaction, possibly due to unfavorable news or investor sentiment.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Nexalin Technology (NXL) stock decreased by 12.4% to $0.78, with a market value of $5.8 million.
The significant price drop indicates negative sentiment or unfavorable news related to the company.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Ontrak (OTRK) stock declined by 7.45% to $0.23, with a market cap of $11.0 million.
The decline in share price indicates negative market reaction, possibly due to unfavorable news or investor sentiment.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Renovaro (RENB) stock decreased by 5.49% to $1.55, with a market cap of $228.6 million.
The stock's decline suggests negative developments or investor sentiment towards the company.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Scinai Immunotherapeutics (SCNI) shares fell 11.47% to $3.09, with a market value of $1.7 million.
The notable decline suggests negative sentiment or developments for the company.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100